2268 logo

WuXi XDC Cayman Inc. Stock Price

SEHK:2268 Community·HK$84.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

2268 Share Price Performance

HK$0
-31.75 (-100.00%)
HK$0
-31.75 (-100.00%)
Price HK$0

2268 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Exceptional growth potential with excellent balance sheet.

1 Risk
3 Rewards

WuXi XDC Cayman Inc. Key Details

CN¥5.1b

Revenue

CN¥3.4b

Cost of Revenue

CN¥1.7b

Gross Profit

CN¥352.7m

Other Expenses

CN¥1.3b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
1.06
33.01%
26.08%
13.7%
View Full Analysis

About 2268

Founded
2013
Employees
2270
CEO
Jincai Li
WebsiteView website
wuxixdc.com

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.

Recent 2268 News & Updates

Is Now The Time To Put WuXi XDC Cayman (HKG:2268) On Your Watchlist?

Nov 07
Is Now The Time To Put WuXi XDC Cayman (HKG:2268) On Your Watchlist?

Recent updates

No updates